SOURCE: Alpharma Inc.

June 06, 2008 08:44 ET

Alpharma to Present at Goldman Sachs Annual Healthcare Conference

BRIDGEWATER, NJ--(Marketwire - June 6, 2008) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the Goldman Sachs Healthcare Conference on Tuesday, June 10, 2008 at 7:30 AM Pacific Time. The conference will be held at the Ritz Carlton in Laguna Niguel, California.

This presentation will be webcast live and can be accessed through Alpharma's website,, through its Investor Support and Company Calendar tabs.

An archived version will be available through December 10, 2008 and can be accessed at the same location.

Alpharma press releases are also available at our website

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 80 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and the FLECTOR® Patch (diclofenac epolamine topical patch) 1.3%. Alpharma is also internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information

  • Contact:
    Jack Howarth
    Vice President
    Investor Relations
    Email Contact